A study led by the Garvan Institute of Medical Research has shown why calcium-binding drugs commonly used to treat people with osteoporosis, or with late-stage cancers that have spread to bone, may also benefit patients with tumours outside the skeleton.
Researchers have disputed the claim that ancient Egyptian royal families suffered from the systemic disease ankylosing spondylitis, which causes inflammation of the spinal joints.
An unsuspected link between the mammalian immune system and the communication systems of simpler organisms such as bacteria has been uncovered.
US engineers have developed a new device for collecting dolphin breath for analysis, which could make it easier to check the animals' health.
Australian researchers have found that omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA), long recognised for helping to prevent heart disease, have another beneficial role to play: increasing the chance of paternity success.
Researchers from Leiden University have found that the precision with which people make decisions can be predicted by measuring pupil size before they are presented with any information about the decision.
ARTES Biotechnology and the Burnet Institute are collaborating to develop a new type of malaria vaccine in a project funded by the PATH Malaria Vaccine Initiative (MVI). The project will focus on strategies to produce vaccines that can block the transmission of malaria infection from mosquitoes to people.
In many species, in-built mechanisms are in place to prevent siblings from breeding with each other. Researchers from the University of Western Australia have investigated such mechanisms in the male guppy, a live-bearing freshwater fish - with unexpected results.
The Children's Oncology Drug Alliance (CODA) has been formed to fast-track development of anticancer therapy for neuroblastoma - the most common form of cancer in infancy.
Californian researchers have recorded a new world record for the fastest running land animal - one which is no bigger than a sesame seed in size.
Researchers have identified a possible mechanism for regrowing damaged nerve fibres in the central nervous system (CNS). Their discovery suggests it could one day be possible to chemically reprogram and repair damaged nerves after spinal cord injury or brain trauma.
A delegation of seven professors from Australian universities recently travelled to China to promote joint research in the musculoskeletal disciplines.
Researchers have conducted the largest randomised, double-blind, placebo-controlled study to date on the effect of OnabotulinumtoxinA (OBA, or Botox) on depression.
Clinical-stage biotechnology company Patrys has released an update on the development program for its anticancer product PAT-LM1. The company's most recent laboratory experiments evaluated the efficacy of PAT-LM1 in blood cancers, including different types of leukaemias and lymphomas.
A study led by Imperial College London has found that statins may provide doctors with a way to slow the progression of multiple sclerosis (MS).